Jan 31, Toronto, Ont. - Theralase Technologies Inc. is pleased to announce that it has been granted notified body approval to place the CE mark on its TLC-1000 series of products, clearing the way for sale of its laser products throughout all 30 member states of the European Union (EU).
CE approval is a mandatory approval stage in the sale of products to European Union (EU) countries. It serves as a declaration that the product meets EU consumer safety, health and environmental requirements.
“Achieving CE approval allows Theralase another opportunity to expand the sale of our medical lasers internationally", stated Roger Dumoulin-White, President and CEO of Theralase Technologies Inc. "By possessing CE approval, in addition to our Health Canada, FDA and certain Latin American and Asian approvals, we are now able to sell our medical lasers to over 63 per cent of the worldmarket (as measured by GDP). This presents a great opportunity for Theralase to expand our revenue generation capability beyond our present markets."
For more information visit the corporate or regulatorywebsite at
www.theralase.com or www.sedar.com
Theralase approved for Europe
What's the deal with HST?As of March 1st, P.E.I. became the fifth province in…
Safe space: Massage therapy for children with Autism Spectrum DisorderAccording to the Public Health Agency of Canada, one in…
PODCAST Episode 3: Patient safety and adverse eventsDonelda Gowan maintains adverse events are common with massage therapy…
Groin and hips of hockey players examined in five-second testFive seconds is enough to assess the status of a…
MTAM Annual Conference
May 3-5, 2019
Remedial Massage Therapists Association AGM and Conference
September 13, 2019